SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-21-000279
Filing Date
2021-03-29
Accepted
2021-03-29 16:16:53
Documents
2
Period of Report
2021-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k032921_8k.htm 8-K 29489
2 EXHIBIT 99.1 PRESS RELEASE OF VOLITIONRX LIMITED REGARDING APPOINTMENT OF DIRECT f8k032921_ex99z1.htm EX-99.1 13594
  Complete submission text file 0001078782-21-000279.txt   44459
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 21781863
SIC: 2835 In Vitro & In Vivo Diagnostic Substances